Please provide your email address to receive an email when new articles are posted on . Use of vaginal estrogen therapy does not affect recurrence risk for women previously diagnosed with endometrial ...

Women who use vaginal estrogen to manage early menopause after treatment for endometrial cancer may not have an increased risk for recurrence.

Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of local, low-dose vaginal estrogen therapy (ET) for survivors. A new study ...

Evidence shows that birth control pills containing the hormones estrogen and progestin can increase the risk of different types of cancers and decrease the risk of others.  Since 1999, the World ...

Younger adult endometrial cancer survivors with short-term exposure to vaginal estrogen therapy (ET) do not have an elevated risk for endometrial cancer recurrence, according to a study published ...

Schonfeld SJ, Hartge P, Pfeiffer, RM, et al. An aggregated analysis of hormonal factors and endometrial cancer risk by parity. Cancer 2012 Dec 20. doi: 10.1002/cncr.27909. [Epub ahead of print] It is ...

It was quite a red flag. Alla Feldbeyn was stunned by unexpected vaginal bleeding in November 2020, many years after she had gone through menopause. The Florida grandmother of four was diagnosed with ...

Cancer is increasingly affecting younger adults worldwide, with a growing body of research linking this rise to obesity and modern lifestyle factors. A recent global study published in the Annals of ...